The clinical disease observed among the NFKB1 variant carriers is characteristic of progressive antibody deficiency associated with recurrent sinopulmonary infections (100% of clinically affected subjects) by encapsulated microbes, such as Streptococcus pneumoniae and Haemophilus influenzae (see Table E1). The gene discussed is NFKB1; the disease is agammaglobulinemia.